BAILARD, INC. - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 60 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 20.98 and the average weighting 0.0%.

Quarter-by-quarter ownership
BAILARD, INC. ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$145,000
-81.4%
115,000
-52.1%
0.01%
-83.0%
Q4 2018$778,000
-31.2%
240,000
-48.8%
0.05%
-19.7%
Q3 2018$1,130,000
-30.5%
469,000
-19.5%
0.07%
-32.0%
Q2 2018$1,625,000
-34.2%
582,400
+12.0%
0.10%
-38.6%
Q1 2018$2,470,000520,1000.16%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q2 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders